


Package Leaflet: Information for the User
solifenacin/tamsulosin cinfamed 6 mg/0.4 mg modified-release tablets EFG
solifenacin succinate/tamsulosin hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
Contents of the pack
2 What you need to know before you take solifenacin/tamsulosin cinfamed
Solifenacin/tamsulosin cinfamed is a combination of two different medicines called solifenacin and tamsulosin in one tablet. Solifenacin belongs to a group of medicines called anticholinergics and tamsulosin belongs to a group of medicines called alpha-blockers.
Solifenacin/tamsulosin cinfamed is used in men to treat both moderate to severe filling symptoms and emptying symptoms of the lower urinary tract caused by bladder problems and by an enlarged prostate (benign prostatic hyperplasia). Solifenacin/tamsulosin cinfamed is used when previous treatment with monotherapy for this condition did not sufficiently relieve the symptoms.
When the prostate gland enlarges, it can cause urinary problems (emptying symptoms) such as delayed urination (difficulty starting urination), reduced urine flow (weak stream), dripping, and a feeling of incomplete emptying of the bladder. At the same time, the bladder is also affected and contracts spontaneously at times when urination is not desired. This causes filling symptoms such as changes in bladder sensation, urgency (a strong and sudden desire to urinate without warning), and having to urinate more frequently.
Solifenacin reduces the involuntary contractions of the bladder and increases the amount of urine that your bladder can hold. Therefore, you can expect to wait longer before you have to go to the bathroom. Tamsulosin allows urine to pass more easily through the urethra and facilitates urination.
Do not takesolifenacin/tamsulosin cinfamedif:
Tell your doctor if you think you have any of these conditions.
Warnings and precautions
Consult your doctor or pharmacist before taking solifenacin/tamsulosin cinfamed if:
Regular medical check-ups are necessary to monitor the development of the condition for which you are being treated.
Solifenacin/tamsulosin cinfamed may affect blood pressure, which can cause dizziness, drowsiness, or rarely, fainting (orthostatic hypotension). You should sit or lie down if you experience any of these symptoms until they have disappeared.
If you are going to have or have scheduled eye surgery due to cataracts or increased pressure in the eyes (glaucoma), please inform your ophthalmologist that you have previously used, are using, or plan to use solifenacin/tamsulosin cinfamed. The specialist can then take the necessary precautions regarding medication and surgical techniques to be used. Ask your doctor if you should postpone or temporarily interrupt taking this medicine when you are going to have eye surgery for cataracts or increased pressure in the eye (glaucoma).
Use in children and adolescents
Do not give this medicine to children and adolescents.
Other medicines and solifenacin/tamsulosin cinfamed
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
It is especially important that you inform your doctor if you are taking:
Solifenacin/tamsulosin cinfamed with food and drinks
Solifenacin/tamsulosin cinfamed can be taken with or without food, according to your preferences.
Pregnancy, breastfeeding, and fertility
Solifenacin/tamsulosin cinfamed is not indicated for use in women.
In men, abnormal ejaculation (ejaculation disorder) has been reported. This means that the semen is not released through the urethra, but instead goes into the bladder (retrograde ejaculation) or that the ejaculated volume is reduced or nonexistent (ejaculatory insufficiency). This phenomenon is harmless.
Driving and using machines
Solifenacin/tamsulosin cinfamed may cause dizziness, blurred vision, fatigue, and less frequently, drowsiness. If you experience these side effects, do not drive or use machines.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are in doubt, consult your doctor or pharmacist again.
The maximum daily dose is one tablet containing 6 mg of solifenacin and 0.4 mg of tamsulosin, taken orally. It can be taken with or without food, depending on your preferences. Do not crush or chew the tablet.
If you take more solifenacin/tamsulosin cinfamed than you should
If you have taken more tablets than you were told to, or if someone else has taken your tablets by mistake, contact your doctor, pharmacist, or hospital immediately for advice.
In case of overdose, your doctor may treat you with activated charcoal; emergency stomach lavage may be useful if performed within one hour of overdose. Do not induce vomiting.
The symptoms of overdose may include: dry mouth, dizziness, and blurred vision, seeing things that are not there (hallucinations), over-excitability, convulsions, difficulty breathing, increased heart rate (tachycardia), inability to completely or partially empty the bladder or to urinate (urinary retention), and/or undesired increase in blood pressure.
In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take solifenacin/tamsulosin cinfamed
Take your next solifenacin/tamsulosin cinfamed tablet as normal. Do not take a double dose to make up for forgotten doses.
If you stop taking solifenacin/tamsulosin cinfamed
If you stop taking solifenacin/tamsulosin cinfamed, your initial symptoms may reappear or worsen. Always consult your doctor if you are considering stopping treatment.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, solifenacin/tamsulosin cinfamed can cause side effects, although not everybody gets them.
The most serious side effect that has been observed with a frequency of less than 1 in 100 men during treatment with solifenacin/tamsulosin in clinical studies is acute urinary retention, which is a sudden inability to urinate. If you think you may have this, go to your doctor immediately. You may need to stop taking solifenacin/tamsulosin cinfamed.
Solifenacin/tamsulosin cinfamed may cause allergic reactions:
If you experience an allergic reaction or a severe skin reaction (e.g. formation of blisters and peeling of the skin), you should inform your doctor immediately and stop using solifenacin/tamsulosin cinfamed. Treatment and/or measures should be applied.
Very common side effects (may affect up to 1 in 10 men)
Common side effects (may affect up to 1 in 10 men)
Uncommon side effects (may affect up to 1 in 100 men)
Rare side effects (may affect up to 1 in 1,000 men)
Very rare side effects (may affect up to 1 in 10,000 men)
Frequency not known (cannot be estimated from the available data)- Decreased appetite
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton or blister after EXP. The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition ofsolifenacin/tamsulosina cinfamed
Each modified-release tablet contains 6 mg of solifenacin succinate, which corresponds to 4.5 mg of solifenacin and 0.4 mg of tamsulosin hydrochloride, which corresponds to 0.37 mg of tamsulosin.
Appearance ofthe productand container content
Solifenacina/tamsulosina cinfamed: the 6 mg/0.4 mg tablets are round (9 mm in diameter), biconvex, red, film-coated, engraved with «6 04» on one side.
PA/aluminum/PVC/aluminum blister pack in an outer box containing 10, 30, 60 or 100 tablets.
Only some pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta 31620 Huarte (Navarra) - Spain
Manufacturer Responsible
Adamed Pharma S.A.
ul. Marszalka Józefa Pilsudskiego 5
95-200 Pabianice
Poland
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
| Medicinal Product Name | |
Poland | Solifenacin succinate + Tamsulosin hydrochloride Adamed | |
Austria | Solifenacin/Tamsulosin Adamed 6 mg/0.4 mg Tabletten mit veränderter | |
Bulgaria | Urifenacin | |
Croatia | Tancer 6 mg/0.4 mg tablete s prilagodenim oslobadanjem | |
France | VECALMYS 6 mg/0.4 mg, comprimé à libération modifiée | |
Greece | VALIREM | |
Italy | Luracin | |
Romania | SOLIFENACIN/TAMSULOZIN ADAMED 6 mg/0.4 mg comprimate cu eliberare modificata | |
Spain | Solifenacina/tamsulosina cinfamed 6 mg/0.4 mg comprimidos de liberación modificada EFG |
Date of the last revision of this leaflet:June 2022
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
You can access detailed and updated information about this medicinal product by scanning the QR code included in the leaflet and packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/88509/P_88509.html
QR code to: https://cima.aemps.es/cima/dochtml/p/88509/P_88509.html
The average price of SOLIFENACIN/TAMSULOSIN CINFAMED 6 mg/0.4 mg EXTENDED-RELEASE TABLETS in October, 2025 is around 30.07 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for SOLIFENACIN/TAMSULOSIN CINFAMED 6 mg/0.4 mg EXTENDED-RELEASE TABLETS – subject to medical assessment and local rules.